Results 101 to 110 of about 24,853 (197)

Infarto agudo de miocardio y embarazo.

open access: yesColombia Medica, 1996
Laura Gabriela Sandor Ille   +1 more
openaire   +1 more source

[Pharmacological adherence and cardiometabolic goals in successfully reperfused acute myocardial infarction]. [PDF]

open access: yesRev Med Inst Mex Seguro Soc
Fabela-Hardy CA   +6 more
europepmc   +1 more source

[Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak]. [PDF]

open access: yesRev Esp Cardiol, 2020
Solano-López J   +16 more
europepmc   +1 more source

Demographic description and outcomes of a metropolitan network for myocardial infarction treatment. [PDF]

open access: yesArch Cardiol Mex, 2021
Gopar-Nieto R   +13 more
europepmc   +1 more source

[Controversies in primary care: Use of beta-blockers after acute myocardial infarction]. [PDF]

open access: yesAten Primaria
Fransi Galiana L   +2 more
europepmc   +1 more source

Risk for shock in people with acute myocardial infarction: a middle-range theory. [PDF]

open access: yesRev Bras Enferm
de Medeiros Dantas AL   +7 more
europepmc   +1 more source

Heparin pretreatment for STEMI primary angioplasty: a meta-analysis. [PDF]

open access: yesREC Interv Cardiol
Roldán-Medina M   +11 more
europepmc   +1 more source

Actuación de enfermería post infarto agudo de miocardio

open access: yes, 2014
El infarto agudo de miocardio (IAM) es una de las enfermedades más comunes en la sociedad actual. La necrosis miocárdica aguda de origen isquémico que se produce antes de los 46 años y denominada IAM prematuro, resulta ser la responsable de un incremento en la cronificación de las enfermedades cardiovasculares. Los programas de salud que contemplan una
Artaso Lapeña, Cristina   +1 more
openaire   +1 more source

[Trends in the epidemiology of acute myocardial infarction in Peru: An analysis of the official SUSALUD records]. [PDF]

open access: yesArch Peru Cardiol Cir Cardiovasc
Hernández-Vásquez A   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy